Database updated: 27 October 2026
Safety Information
Medsafe Online Recall Database
Detail of Recall
| Type of Product: | Medicine |
| Medsafe Reference: | 20660 |
| Brand Name: | Fludarabine Ebewe |
| Dose Form/Strength: | Concentrate for injection 25 mg/mL |
| Affected: | EM8109 |
| Recalling Organisation: | Novartis New Zealand Ltd Private Office 3.15 12 Madden Street Wynyard Quarter Auckland 1010 |
| Contact Information: | |
| Manufacturer: | EBEWE Pharma GmbH Nfg KG |
| Issue: | Discovery of yellow-brownish particles in Fludarabine phosphate 50mg/2ml vials for infusion during a retain sample check in the course of a monitoring program. |
| Recall action type: | Recall |
| Recall action: | Recall |
| Level of recall: | Hospital/Pharmacy/Laboratory |
| Date Commenced: | 26/9/2016 |
